Cleveland Clinic Foundation Hematology and Medical Oncology

Topics

• Renal cell carcinoma treatment 501
• Acute Myeloid Leukemia Research 362
• Lymphoma Diagnosis and Treatment 257
• Multiple Myeloma Research and Treatments 208
• Venous Thromboembolism Diagnosis and Management 193
• Hematopoietic Stem Cell Transplantation 189
• CAR-T cell therapy research 188
• Chronic Lymphocytic Leukemia Research 161
• Bladder and Urothelial Cancer Treatments 155
• Cancer Immunotherapy and Biomarkers 123
• Myeloproliferative Neoplasms: Diagnosis and Treatment 109
• Acute Lymphoblastic Leukemia research 96

Most cited

1. Post-acute COVID-19 syndrome.

   Nature medicine · 2021 · 3,389 citations · Toni Choueiri

2. Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.

   The New England journal of medicine · 2022 · 2,268 citations · Halle Moore

3. Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology

   Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 922 citations · James Stevenson

4. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021.

   International journal of molecular sciences · 2022 · 1,007 citations · Youssef Bouferraa

5. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 1,255 citations · James Stevenson

6. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 560 citations · Jame Abraham

7. Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer.